NCT04330911

Brief Summary

Diabetes, beyond glycemic control, is a complex chronic disease that requires continuous medical care with multifactorial risk reduction strategies. It is necessary to reduce the likelihood of complications and additional problems that may develop in the long term. For this reason, guiding the patient to manage the disease process, equipping and supporting the patient with the necessary information is critical to prevent acute problems. Exercise is the primary treatment method for diabetes patients. Exercise; It is the main treatment method used to increase aerobic capacity and improve respiratory capacity due to the positive effect it has on the body's structure and systems.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 2, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

1 month

First QC Date

March 27, 2020

Last Update Submit

April 7, 2020

Conditions

Outcome Measures

Primary Outcomes (15)

  • Incremental Shuttle Walk Test-ISWT

    Aerobic Capacity

    Baseline Assessment

  • Incremental Shuttle Walk Test-ISWT

    Aerobic Capacity

    End of the exercise period assessment (end of the 6. weeks)

  • Incremental Shuttle Walk Test-ISWT

    Aerobic Capacity

    End of the follow-up period assessment (end of the 12. weeks)

  • Digital Spirometer

    FVC parameters were evaluated automatically.

    Baseline Assessment

  • Digital Spirometer

    FVC parameters were evaluated automatically.

    End of the follow-up period assessment (end of the 6. weeks)

  • Digital Spirometer

    FVC parameters were evaluated automatically.

    End of the follow-up period assessment (end of the 12. weeks)

  • Digital Spirometer

    FEV1 were evaluated automatically.

    Baseline Assessment

  • Digital Spirometer

    FEV1 were evaluated automatically.

    End of the follow-up period assessment (end of the 6. weeks)

  • Digital Spirometer

    FEV1 were evaluated automatically.

    End of the follow-up period assessment (end of the 12. weeks)

  • Digital Spirometer

    FEV1/FVC were evaluated automatically.

    Baseline Assessment

  • Digital Spirometer

    FEV1/FVC were evaluated automatically.

    End of the follow-up period assessment (end of the 6. weeks)

  • Digital Spirometer

    FEV1/FVC were evaluated automatically.

    End of the follow-up period assessment (end of the 12. weeks)

  • Digital Spirometer

    PEF parameters were evaluated automatically.

    Baseline Assessment

  • Digital Spirometer

    PEF parameters were evaluated automatically.

    End of the follow-up period assessment (end of the 6. weeks)

  • Digital Spirometer

    PEF parameters were evaluated automatically.

    End of the follow-up period assessment (end of the 12. weeks)

Study Arms (2)

The HIIT Group (High Intensity Interval Training Group)

EXPERIMENTAL
Procedure: Aerobic Exercise

The MICT Group (Moderate Intensity Continous Training Group)

EXPERIMENTAL
Procedure: Aerobic Exercise

Interventions

Exercise loading is determined by increasing the heart rate. This loading calculated by Karvonen formulas (maximum %80 of Heart Rate)

The HIIT Group (High Intensity Interval Training Group)The MICT Group (Moderate Intensity Continous Training Group)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with type-2 diabetes mellitus,
  • patients who have sedentary lifestyle (\<3 bouts of exercise per week and \<30 minutes aerobic exercise period),
  • non-smoking patients,
  • not to lose more than 5% of total body weight in the last 6 months,
  • blood pressure\<160/100 mmHg

You may not qualify if:

  • alcohol addiction in the last 12 months,
  • patients who use insulin hormone,
  • patients who have neuropathy or retinopathy,
  • patients who have an acute cardiac event in the last 6 weeks,
  • patients who have a disease at least 2 weeks in the last 1 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, 34083, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: High-Intensity Interval Training Group (HIIT): The HIIT exercise protocol involved 28 minutes of treadmill efforts. The patients performed the interval training for 4 minutes with 80%HRmax and active recovery period maintained for 3 minutes with 60% HRmax on the treadmill with Karvonen formula.This protocol repeated 4 times in a session for 6 weeks. Moderate Intensity Continous Training (MICT): The MICT exercise protocol performed with %60 HRmax for 28 minutes for 6 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

March 27, 2020

First Posted

April 2, 2020

Study Start

February 1, 2019

Primary Completion

March 15, 2019

Study Completion

May 1, 2019

Last Updated

April 9, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations